AbbVie in its public offering of $4 billion of senior unsecured notes
On February 18, 2025, AbbVie, Inc. priced a registered public offering of $4 billion aggregate principal amount of senior unsecured notes. AbbVie intends to use the net proceeds from the notes offering (a) to repurchase, redeem, satisfy and discharge, defease, make a tender offer for, or otherwise repay at maturity certain of its series of senior notes which have stated maturities in 2025, and, in each case, to pay any premium and accrued and unpaid interest in respect thereof, and/or (b) for general corporate purposes. BofA Securities, Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, Barclays Capital Inc. and Mizuho Securities USA LLC are acting as joint book-running managers of the offering.
Wachtell, Lipton, Rosen & Katz is serving as legal advisor to AbbVie.